The U.S. Senate has voted in support of the confirmation of controversial nominee Robert Califf, MD, to be the FDA’s new commissioner. Dr. Califf’s nomination was fraught with criticism that his previous financial ties with drug companies would reduce his willingness to take on the pharmaceutical industry in the ongoing battle over the country’s opioid epidemic. Dr. Califf was confirmed by an 89 to 4 vote.
“Dr. Califf has demonstrated a long and deep commitment to